Wearable Cardioverter Defibrillator

DEVICE4 trials

Sponsors

Zoll Medical Corporation

Conditions

Cardiac ArrythmiasCardiac EventHeart FailureHeart Failure Low OutputLeft Ventricular DysfunctionSudden Cardiac ArrestSudden Cardiac Death

Unknown Phase

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

TerminatedNCT02481206

Zoll Medical CorporationSudden Cardiac Arrest, Sudden Cardiac Death

Start: 2015-06-30End: 2017-12-31Updated: 2021-01-19

Heart Failure Optimization Study

CompletedNCT03016754

Zoll Medical CorporationHeart Failure, Heart Failure Low Output, Sudden Cardiac Arrest +1

Start: 2017-03-01End: 2022-06-01Updated: 2025-03-24

LifeVest Safety and Efficacy in Real Life Settings in France

CompletedNCT03319160

Zoll Medical CorporationCardiac Arrythmias, Cardiac Event, Left Ventricular Dysfunction +1

Start: 2017-02-02End: 2019-03-30Updated: 2024-12-09

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

TerminatedNCT04292405

Zoll Medical CorporationHeart Failure

Start: 2020-01-23End: 2025-09-30Updated: 2025-10-30

Related Papers

Dynamic changes in nocturnal heart rate predict short-term cardiovascular events in patients using the wearable cardioverter-defibrillator: from the WEARIT-France cohort study

EP Europace2023-04-0618 citations